Asbestos, Lung Cancers, and Mesotheliomas: From Molecular Approaches to Targeting Tumor Survival Pathways
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Fifteen years have passed since we published findings in the AJRCMB demonstrating that induction of early response fos/jun proto-oncogenes in rodent tracheal and mesothelial cells correlates with fibrous geometry and pathogenicity of asbestos. Our study was the first to suggest that the aberrant induction of signaling responses by crocidolite asbestos and erionite, a fibrous zeolite mineral associated with the development of malignant mesotheliomas (MMs) in areas of Turkey, led to altered gene expression. New data questioned the widely held belief at that time that the carcinogenic effects of asbestos in the development of lung cancer and MM were due to genotoxic or mutagenic effects. Later studies by our group revealed that proto-oncogene expression and several of the signaling pathways activated by asbestos were redox dependent, explaining why antioxidants and antioxidant enzymes were elevated in lung and pleura after exposure to asbestos and how they alleviated many of the phenotypic and functional effects of asbestos in vitro or after inhalation. Since these original studies, our efforts have expanded to understand the interface between asbestos-induced redox-dependent signal transduction cascades, the relationship between these pathways and cell fate, and the role of asbestos and cell interactions in development of asbestos-associated diseases. Of considerable significance is the fact that the signal transduction pathways activated by asbestos are also important in survival and chemoresistance of MMs and lung cancers. An understanding of the pathogenic features of asbestos fibers and dysregulation of signaling pathways allows strategies for the prevention and therapy of asbestos-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationMechanisms in the Pathogenesis of Asbestosis and Silicosis
MOSSMAN, B. T., & CHURG, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9707141 · Cited by 971
Self-citationMultiple roles of oxidants in the pathogenesis of asbestos-induced diseases
Shukla, A., Gulumian, M., Hei, T. K., Kamp, D., Rahman, Q., & Mossman, B. T. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00060-1 · Cited by 288
Self-citationCragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., & Scott, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35437 · Cited by 207
Persistent induction of c-fos and c-jun expression by asbestos.
Heintz, N. H., Janssen, Y. M., & Mossman, B. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3299 · Cited by 205
Self-citationMossman, B. T., Marsh, J. P., Sesko, A., Hill, S., Shatos, M. A., Doherty, J., Petruska, J., Adler, K. B., Hemenway, D., Mickey, R., et al. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.5_pt_1.1266 · Cited by 163
Self-citationBoylan, A. M., Sanan, D. A., Sheppard, D., & Broaddus, V. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118246 · Cited by 86
Goldberg, J. L., Zanella, C. L., Janssen, Y. M. W., Timblin, C. R., Jimenez, L. A., Vacek, P., Taatjes, D. J., & Mossman, B. T. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2991 · Cited by 78
Self-citationWu, J., Liu, W., Koenig, K., Idell, S., & Broaddus, V. C. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l916 · Cited by 40
Targeting the MEK1 Cascade in Lung Epithelium Inhibits Proliferation and Fibrogenesis by Asbestos
Manning, C. B., Sabo-Attwood, T., Robledo, R. F., MacPherson, M. B., Rincón, M., Vacek, P., Hemenway, D., Taatjes, D. J., Lee, P. J., & Mossman, B. T. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0382oc · Cited by 20
Self-citation
Cited by
Malignant mesothelioma: Facts, Myths, and Hypotheses
Carbone, M., Ly, B. H., Dodson, R. F., Pagano, I., Morris, P. T., Dogan, U. A., Gazdar, A. F., Pass, H. I., & Yang, H. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22724 · Cited by 376
Schinwald, A., Murphy, F. A., Jones, A., MacNee, W., & Donaldson, K. (2012) · ACS Nano · doi:10.1021/nn204229f · Cited by 374
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases
Sayan, M., & Mossman, B. T. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0162-4 · Cited by 296
Self-citationMolecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma
Carbone, M., & Yang, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2259 · Cited by 229
“HGF activation is mediated through the phosphatidylinositol-3-kinase (PI3K)/MEK5/Fos-related antigen 1 (Fra1) feedback pathway (19).”
InfluentialMolecular basis of asbestos-induced lung disease
Liu, G., Cheresh, P., & Kamp, D. W. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163942 · Cited by 213
Pulmonary Endpoints (Lung Carcinomas and Asbestosis) Following Inhalation Exposure to Asbestos
Mossman, B. T., Lippmann, M., Hesterberg, T. W., Kelsey, K. T., Barchowsky, A., & Bonner, J. C. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.556047 · Cited by 192
Self-citationSchinwald, A., Murphy, F. A., Prina-Mello, A., Poland, C. A., Byrne, F., Movia, D., Glass, J. R., Dickerson, J. C., Schultz, D. A., Jeffree, C. E., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs171 · Cited by 181
Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases
Huang, S. X. L., Jaurand, M.-C., Kamp, D. W., Whysner, J., & Hei, T. K. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.556051 · Cited by 163
“A better understanding of the dysregulation of these signaling pathways may benefit the prevention and therapy of asbestos-related mesothelioma (Heintz et al., 2010).”
BackgroundKrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung
Maeda, Y., Tsuchiya, T., Hao, H., Tompkins, D. H., Xu, Y., Mucenski, M. L., Du, L., Keiser, A. R., Fukazawa, T., Naomoto, Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64048 · Cited by 163
Reactive Oxygen Species a Double-Edged Sword for Mesothelioma
Benedetti, S., Nuvoli, B., Catalani, S., & Galati, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4253 · Cited by 97
“Survival pathways may be activated by direct interaction of asbestos fibers with receptors on the cell surface and by interaction with integrins, or via elaboration of ROS, and are often up-regulated in MMs, in which they contribute to tumor development, homeostasis, and resistance to chemotherapy [74] (Figure 3).”
BackgroundKuempel, E. D., Jaurand, M.-C., Møller, P., Morimoto, Y., Kobayashi, N., Pinkerton, K. E., Sargent, L. M., Vermeulen, R. C. H., Fubini, B., & Kane, A. B. (2017) · Critical Reviews in Toxicology · doi:10.1080/10408444.2016.1206061 · Cited by 89
Altomare, D. A., Menges, C. W., Xu, J., Pei, J., Zhang, L., Tadevosyan, A., Neumann-Domer, E., Liu, Z., Carbone, M., Chudoba, I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018828 · Cited by 65
Zolondick, A. A., Gaudino, G., Xue, J., Pass, H. I., Carbone, M., & Yang, H. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-12 · Cited by 41
“It was demonstrated that upregulation of the AP-1 component Fra-1 in response to asbestos modulates malignant transformation of mesothelial cells (31,32).”
BackgroundAsbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials
Felley-Bosco, E., & MacFarlane, M. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00146 · Cited by 23
Novel Compound 1, 3-bis (3, 5-dichlorophenyl) urea Inhibits Lung Cancer Progression
Singhal, S. S., Figarola, J., Singhal, J., Nagaprashantha, L., Berz, D., Rahbar, S., & Awasthi, S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.022 · Cited by 14
Di Maria, G., Bruno, C., Vancheri, A., Di Maria, C., & Comba, P. (2022) · Encyclopedia of Respiratory Medicine · doi:10.1016/b978-0-08-102723-3.00061-5 · Cited by 1
Metadata
- Authors
- Heintz, N. H., Janssen-Heininger, Y. M. W., & Mossman, B. T.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 42
- Issue
- 2
- Pages
- 133-139
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2011021235
- Cited by
- 182
- References
- 10
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.